NCT05438563View on ClinicalTrials.gov

MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 6, 2022

Primary Completion Date

March 7, 2027

Study Completion Date

March 7, 2027

Conditions
Prostate CarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8
Interventions
PROCEDURE

MRI-Guided Transurethral Ultrasound Ablation

Undergo MRI-Guided TULSA

OTHER

Questionnaire Administration

Ancillary studies

PROCEDURE

Digital Rectal Examination

Undergo DRE

PROCEDURE

Cystoscopy

Undergo cystoscopy

PROCEDURE

Biopsy

Undergo biopsy

PROCEDURE

Bone Scan

Undergo bone scan

PROCEDURE

PSMA PET Scan

Undergo PSMA PET

PROCEDURE

Multiparametric Magnetic Resonance Imaging

Undergo mpMRI

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05438563 - MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer | Biotech Hunter | Biotech Hunter